Patients suffering from Alzheimer’s disease show a marked reduction in AChE activity (Davies and Maloney, 1976; Coyle et al., 1983) and the use of drugs boosting cholinergic function can ameliorate memory deficits (Davis et al., 1979). The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.